ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 118 filers reported holding ERASCA INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,414,668 | -26.2% | 718,105 | +3.4% | 0.00% | – |
| Q2 2023 | $1,917,532 | -2.9% | 694,758 | +5.9% | 0.00% | – |
| Q1 2023 | $1,975,422 | -20.7% | 656,286 | +13.5% | 0.00% | -100.0% |
| Q4 2022 | $2,492,288 | -41.4% | 578,257 | +6.1% | 0.00% | 0.0% |
| Q3 2022 | $4,250,000 | +58.5% | 544,878 | +13.2% | 0.00% | 0.0% |
| Q2 2022 | $2,682,000 | -34.4% | 481,508 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $4,086,000 | +38.8% | 475,131 | +151.5% | 0.00% | – |
| Q4 2021 | $2,943,000 | -24.1% | 188,905 | +3.4% | 0.00% | -100.0% |
| Q3 2021 | $3,877,000 | – | 182,709 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $21,779,441 | 14.15% |
| EDBI Pte Ltd | 888,888 | $1,751,109 | 1.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 1,926,000 | $3,794,220 | 1.28% |
| Cormorant Asset Management, LP | 10,813,246 | $21,302,095 | 1.24% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $615,625 | 0.64% |
| Artal Group S.A. | 4,721,194 | $9,301 | 0.40% |
| PFM Health Sciences, LP | 3,930,633 | $7,743,347 | 0.36% |
| ARMISTICE CAPITAL, LLC | 8,356,000 | $16,461,320 | 0.25% |
| SANDERS MORRIS HARRIS LLC | 425,297 | $816,569 | 0.17% |
| Prosight Management, LP | 264,710 | $521,479 | 0.16% |